Insider Selling: Merge Healthcare CEO Sells 50,000 Shares of Stock (MRGE)
Merge Healthcare (NASDAQ:MRGE) CEO Justin C. Dearborn sold 50,000 shares of the stock on the open market in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $2.33, for a total value of $116,500.00. Following the transaction, the chief executive officer now directly owns 350,000 shares of the company’s stock, valued at approximately $815,500. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Separately, analysts at Topeka Capital Markets initiated coverage on shares of Merge Healthcare in a research note on Thursday, June 12th. They set a “buy” rating and a $3.00 price target on the stock.
Shares of Merge Healthcare (NASDAQ:MRGE) traded up 0.42% on Monday, hitting $2.38. The stock had a trading volume of 413,759 shares. Merge Healthcare has a 52 week low of $1.97 and a 52 week high of $3.20. The stock’s 50-day moving average is $2.34 and its 200-day moving average is $2.33. The company’s market cap is $227.7 million.
Merge Healthcare (NASDAQ:MRGE) last announced its earnings results on Wednesday, July 30th. The company reported $0.05 EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.02) by $0.07. The company had revenue of $53.80 million for the quarter, compared to the consensus estimate of $53.30 million. During the same quarter in the prior year, the company posted $0.01 earnings per share. The company’s quarterly revenue was down 5.9% on a year-over-year basis. Analysts expect that Merge Healthcare will post $0.15 EPS for the current fiscal year.
Merge Healthcare Incorporated (NASDAQ:MRGE) develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians.
Receive News & Ratings for Merge Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merge Healthcare Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.